OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
March 01, 2023
The trends shaping the growth of the biologics outsourcing industry demand attention.
June 01, 2022
When considering whether to outsource work to a CRO, there are a number of factors to assess, including the type of work that may be outsourced, regulatory considerations, and needs for the study.
October 14, 2021
Pharmalex has launched the Biopharma Excellence brand, a new service line that combines the expertise of PharmaLex, ERA Consulting, and Biopharma Excellence.
July 01, 2020
The COVID-19 pandemic has created a rise in demand for R&D and a shift in focus for some contract organizations.
June 30, 2020
The company now offers its CONFIDENCE virus clearance services to support validation of viral clearance processes.
July 01, 2018
This article highlights 15 years of changes in biopharmaceutical manufacturing.
May 15, 2017
Effective communication between contract manufacturing organizations and pharmaceutical company clients relies on well-defined master service and quality agreements.
FDA’s focus on the quality culture and its request for quality metrics may ensure a successful company-CMO relationship.
June 15, 2016
New drug approval policies promote industry growth and injectable contract manufacturing opportunities in China.
Biopharmaceutical manufacturers continue to put quality at the forefront of their relationships.